MedPath

An Exploratory PET-study of Deposition, Disposition and Brain Uptake of [11C]Nicotine After Inhalation of 2 Nicotine Formulations Via the myBluTM E-cigarette in Smokers

Not Applicable
Completed
Conditions
Healthy Volunteers
Registration Number
NCT04780815
Lead Sponsor
Imperial Brands PLC
Brief Summary

This is a single-center, exploratory positron emission tomography (PET) study of deposition, disposition and brain uptake \[11C\]nicotine when given to smokers as two different formulations via mybluTM e-cigarette system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Body mass index ≥18.0 and ≤ 30.0 kg/m2
  • Habitual daily cigarette smoker
  • Women have to be of non-child bearing potential
Exclusion Criteria
  • History of any clinically significant disease
  • Relevant concomitant medication
  • Any clinically significant condition
  • Malignancy within the past 5 years
  • Positif for HIV, hepatitis B or C
  • Untreated hypertension
  • Previous participation to a PET-study or other nuclide medical study
  • Previous exposure to significant radiation
  • Negative results of the modified Allen test on both arms at screening
  • Alcohol or drug abuse

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Lung PET40 minutes

Peak accumulation of \[11C\]nicotine deposited in the lung during 40 minutes after product administration, using dynamic PET Digital Imaging and Communications in Medicine (DICOM) images over the lungs

Brain PET30 minutes

Peak accumulation of nicotine deposited in the brain during 30 minutes after product administration, using dynamic PET Digital Imaging and Communications in Medicine (DICOM) images over the brain

Oral Cavity PET40 minutes

Peak accumulation of nicotine deposited in the oral cavity during 40 minutes after product administration, using dynamic PET Digital Imaging and Communications in Medicine (DICOM) images over the oral cavity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PET Centre, Uppsala University Hospital

🇸🇪

Uppsala, Sweden

PET Centre, Uppsala University Hospital
🇸🇪Uppsala, Sweden

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.